Minerva Neurosciences | NERV - Рыночная капитализация





Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Adma Biologics USD 2.15B 2.19B 2026-03
ALKERMES USD 8.73B 2.85B 2026-06
Alterity Therapeutics Limited AUD 39M 17M 2026-09
AstraZeneca USD 289.99B 11.26B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cipla INR 1.18T 194.93B 2026-06
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.29M 475.62M 2026-03
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 1.13T 260.54B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Merck USD 317.37B 20.27B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novavax USD 1.09B 316M 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12